Could pharmacogenetics play a role as predictor in treatment of depressive disorders?
作者信息
Lee Min-Soo
出版信息
World J Biol Psychiatry. 2007;8(1):2-3. doi: 10.1080/15622970601183452.
PMID:17366343
Abstract
摘要
相似文献
1
Could pharmacogenetics play a role as predictor in treatment of depressive disorders?
World J Biol Psychiatry. 2007;8(1):2-3. doi: 10.1080/15622970601183452.
2
Pharmacogenetics in modern psychiatry.
Psychiatr Danub. 2007 Sep;19(3):231-3.
3
Pharamacogenetics and antidepressant treatment in integrative psychiatry perspective.
Psychiatr Danub. 2008 Sep;20(3):399-401.
4
Insights and barriers to clinical use of serotonin transporter pharmacogenetics in antidepressant therapy.
Pharmacogenomics. 2018 Feb;19(3):167-170. doi: 10.2217/pgs-2017-0196. Epub 2018 Jan 12.
5
Pharmacotherapeutic approaches to treatment-resistant depression.
JAAPA. 2003 Mar;16(3):32-4, 37-8, 40 passim.
6
Serotonin transporter polymorphism and response to SSRIs in major depression and relevance to anxiety disorders and substance abuse.
Pharmacogenomics. 2000 Aug;1(3):335-41. doi: 10.1517/14622416.1.3.335.
7
Pharmacogenomics and antidepressant drugs.
Ann Med. 2006;38(2):82-94. doi: 10.1080/07853890600551045.
8
[The influence of genetic variations on the effect of selective serotonin reuptake inhibitors].
Ugeskr Laeger. 2007 Apr 16;169(16):1439-41.
9
Anticipated outcomes from introduction of 5-HTTLPR genotyping for depressed patients: an expert Delphi analysis.
Public Health Genomics. 2010;13(7-8):406-14. doi: 10.1159/000313467. Epub 2010 Jul 6.
10
TORDIA: unique opportunity to explore half-life theory.
Am J Psychiatry. 2009 Aug;166(8):936; author reply 936-7. doi: 10.1176/appi.ajp.2009.09050601.
Zotero 插件